How a tool is helping execs define and measure value in oncology.
Non Hodgkin Lymphoma
CD20-directed antibody indicated for several cancers and other conditions.
How targeted therapy could be the pathway to improved cancer treatment.
Top oncology experts share how they deliver these therapies to patients in need.
A record number of new oncology treatments launched in the US last year and spending on cancer drugs soared. Here are the top 6 cancer drug trends revealed in the report.
Drug targets the CD79b protein on B-cells.
With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.
A new study investigates whether PET scans can help guide treatment in patients with aggressive non-Hodgkin lymphomas.
The National Comprehensive Cancer Network recently updated its guidelines for Non-Hodgkin's Lymphoma to include new therapeutic options, as well as changes to diagnostic criteria and staging.